Branch retinal vein occlusion: Classification and treatment

Ophthalmologica

Volumn 223, Issue 5, 2009, Pages 298-305

  Battaglia Parodi, Maurizio ^a   Bandello, Francesco ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Anti vascular endothelial growth factor; Branch retinal vein occlusion; Combined therapy; Corticosteroids; Laser treatment; Sheathotomy; Vitrectomy

Indexed keywords

ALTEPLASE; BEVACIZUMAB; DEXAMETHASONE; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE;

BRANCH RETINAL ARTERY OCCLUSION; BRANCH RETINAL VEIN OCCLUSION; CATARACT; CILIARY DISK; CLINICAL TRIAL; CONTROL GROUP; DISEASE CLASSIFICATION; DRUG EFFICACY; ENDOPHTHALMITIS; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HEMISPHERIC RETINAL VEIN CCLUSION; HEMODILUTION; HUMAN; HYPERBARIC OXYGEN; INTRAOCULAR PRESSURE; LASER COAGULATION; LONG TERM CARE; LOW LEVEL LASER THERAPY; MACULAR BRANCH RETINAL VEIN OCCLUSION; RETINA HEMORRHAGE; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RETINA VEIN OCCLUSION; REVIEW; SIDE EFFECT; VITRECTOMY;

ANGIOGENESIS INHIBITORS; COMBINED MODALITY THERAPY; GLUCOCORTICOIDS; HUMANS; LASER COAGULATION; OPHTHALMOLOGIC SURGICAL PROCEDURES; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64549148797     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000213640     Document Type: Review

References (112)

1. Orth D, Patz A: Retinal branch vein occlusion. Surv Ophthalmol 1978; 22: 357-376.
2. Klein R, Klein B, Moss SE, Meuer SM: the epidemiology of retinal vein occlusion: The Beaver Dam Eye Study. Trans Am Ophthal-mol Soc 2001; 98: 133-141.
3. Feist RM, Ticho BH, Shapiro MJ, Farber M: Branch retinal vein occlusion and quadran-tic variation in arteriovenous crossings. Am J Ophthalmol 1992; 113: 664-668.
4. Jensen VA: Clinical studies of tributary thrombosis in central retinal vein. Acta Ophthalmol Suppl 1936; 10: 1-193.
5. Kumar B, Yu D, Morgan WH, et al.: The distribution of angioarchitectural changes within the vicinity of arteriovenous crossing in branch retinal vein occlusion. Ophthalmology 1998; 105: 424-427.
6. Frangieh GT, Green R, Barraquer-Somers E, Finkelstein D: Histopathologic study of nine branch retinal vein occlusions. Arch Oph-thalmol 1982; 100: 1132-1140.
7. Baglivo E, Dosso A, Pournaras C: Thrombus and branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 1997; 235: 10-13.
8. Hayreh SS, Zimmerman MB, Podhajsky P: Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117: 429-441.
9. Appiah AP, Greenidge KC: Factors associated with retinal vein occlusions in Hispanics. Ann Ophthalmol 1987; 19: 307-309.
10. Appiah AP, Trempe CL: Risk factors associated with branch versus central retinal vein occlusion. Ann Ophthalmol 1989; 21: 153-157.
11. Appiah AP, Trempe CL: Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions. Ophthalmology 1989; 96: 364-366.
12. Coscas G, Dhermy P, Gaudric A; Société Française veineuses rétiniennes. Paris, Masson, 1978.
13. Johnston RL, Brucker AJ, Steinmann W, et al.: Risk factors of branch retinal vein occlusion. Arch Ophthalmol 1985; 103: 1831-1832.
14. Rath EZ, Frank RN, Shin DH, Kim C: Risk factors for retinal vein occlusions. Ophthalmology 1992; 99: 509-514.
15. vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008; 126: 692-699.
16. The Eye Disease Case-Control Study Group: Risk factors for branch retinal vein occlusion. Am J Ophthalmol 1993; 116: 286-296.
17. Frucht J, Shapiro A, Merin S: Intraocular pressure in retinal vein occlusion. Br J Oph-thalmol 1984; 68: 26-28.
18. Cole MD, Dodson PM, Hendeles S: Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension. Br J Ophthalmol 1989; 73: 693-698.
19. McGrath MA, Wechsler F, Hunyor ABL, Penny R: Systemic factors contributory to retinal vein occlusion. Arch Intern Med 1978; 138: 216-220.
20. Dodson PM, Galton DJ, Hamilton AM, Black RK: Retinal vein occlusion and the prevalence of lipoprotein abnormalities. Br J Oph-thalmol 1982; 66: 161-164.
21. Trope GE, Lowe GDO, McArdle BM: Abnormal blood viscosity and hemostasis in longstanding retinal vein occlusion. Br J Ophthalmol 1983; 67: 137-142.
22. Remky A, Arend O, Jung F, et al.: Haemorhe-ology in patients with branch retinal vein occlusion with and without risk factors. Grae-fes Arch Clin Exp Ophthalmol 1996; 234 (suppl 1):S8-S12.
23. Glacet-Bernard A, Bayani N, Chretien P, et al.: Antiphospholipid antibodies in retinal vein occlusion: a prospective study of 75 patients. Arch Ophthalmol 1994; 112: 790-795.
24. Majji AB, Janarthanan M, Naduvilath TJ: Significance of refractive status in branch retinal vein occlusion: a case-control study. Retina 1997; 17: 200-204.
25. Timmerman EA, de Lavalette VW, van den Brom HJB: Axial length as risk factor to branch retinal vein occlusion. Retina 1989; 17: 196-199.
26. Bandello F, Tavola A, Pierro L, et al.: Axial length and refraction in retinal vein occlusions. Ophthalmologica 1998; 212: 133-135.
27. Cursiefen C, Handel A, Schonherr U, Nau-mann GO: Pseudoexfoliation syndrome in patients with retinal vein branch and central vein thrombosis. Klin Monatsbl Augenheilkd 1997; 211: 17-21.
28. Henkind P, Wise GN: Retinal neovascular-ization, collaterals, and vascular shunts. Br J Ophthalmol 1974; 58: 413-422.
29. Pieris SJ, Hill DW: Collaterals vessels in branch retinal vein occlusion. Trans Oph-thalmol Soc UK 1982; 102: 178-181.
30. Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF: Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983; 90: 488-506.
31. Silva RM, Faria de Abreu JR, Cunha-Vaz JG: Blood-retina barrier in acute retinal branchPRA, Wong DT, Ray vein occlusion. Graefes Arch Clin Exp Oph-thalmol 1995; 233: 721-726.
32. Michels RG, Gass JDM: The natural course of retinal branch vein obstruction. Trans Am Acad Ophthalmol Otolaryngol 1974; 78: 166-177.
33. Gutman FA, Zegarra H: The natural course of temporal retinal branch vein occlusion. Trans Am Acad Ophthalmol Otolaryngol 1974; 78: 178-192.
34. Blankenship GW, Okun E: Retinal tributary vein occlusion: history and management by photocoagulation. Arch Ophthalmol 1973; 89: 363-368.
35. Trempe CL, Takahashi M, Topilow HW: Vitreous changes in retinal branch vein occlusion. Ophthalmology 1981; 88: 681-687.
36. Branch Vein Occlusion Study Group: Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: a randomized clinical trial. Arch Ophthalmol 1986; 104: 34-41.
37. Hayreh SS, Rubenstein L, Podhajsky P: Argon laser scatter photocoagulation in treatment of branch retinal vein occlusion: a prospective clinical trial. Ophthalmologica 1993; 206: 1-14.
38. Apostolopoulos M, Koutsandrea C, Chat-joulis D, et al.: Late complications in branch retinal vein occlusion. Int Ophthalmol 1996; 19: 281-285.
39. Takahashi MK, Hikichi T, Akiba J, Yoshida A, Trempe CL: Role of the vitreous and macular edema in branch retinal vein occlusion. Ophthalmic Surg Lasers 1997; 28: 294-299.
40. Kado M, Trempe CL: Role of the vitreous in branch retinal vein occlusion. Am J Oph-thalmol 1988; 105: 20-24.
41. Schepens CL, Avila MP, Jalkh AE, Trempe CL: Role of the vitreous in cystoid macular edema. Surv Ophthalmol 1984; 28: 499-504.
42. Finkelstein D, Clarkson J, Diddie K, Hillis A, Kimball A, Orth D, Trempe C; The Branch Vein Occlusion Study Group: Branch vein occlusion: retinal neovascularization outside the involved segment. Ophthalmology 1982; 89: 1357-1361.
43. Greer DV, Constable IJ, Cooper RL: Macular oedema and retinal branch vein occlusion. Aust J Ophthalmol 1980; 8: 207-209.
44. Gass JDM: Stereoscopic atlas of macular diseases. St. Louis, Mosby, 1970, p 154.
45. Chess J, Eichen AL: Rhegmatogenous retinal detachment associated with branch vein occlusion. Ann Ophthalmol 1989; 21: 309-311.
46. Ikuno Y, Tano Y, Lewis JR, Ikeda T, Sato Y: Retinal detachment after branch retinal vein occlusion: influence of the type of break on the outcome of vitreous surgery. Ophthalmology 1997; 104: 27-32.
47. Ikuno Y, Ikeda T, Sato Y, Tano Y: Tractional retinal detachment after branch retinal vein occlusion: influence of disc neovasculariza- Retinaltion on the outcome of vitreous surgery. Ophthalmology 1998; 105: 417-423.
48. Metzler U, Hollmann R, Kaskel D: Netzhaut-ablösungen bei Verschlüssen der Zentral-vene oder ihrer Äste. Klin Monatsbl Augen-heilkd 1974; 164: 251-254.
49. Schatz H, Yannuzzi L, Stransky TJ: Retinal detachment secondary to branch vein occlusion. Part I. Ann Ophthalmol 1976; 8: 1437-1452.
50. Schatz H, Yannuzzi L, Stransky TJ: Retinal detachment secondary to branch vein occlusion. Part II. Ann Ophthalmol 1976; 8: 1461-1471.
51. Ravalico G, Battaglia Parodi M: Exudative retinal detachment subsequent to retinal vein occlusion. Ophthalmologica 1992; 205: 77-82.
52. Battaglia Parodi M, Isola V: Branch retinal vein occlusion and exudative retinal detachment: pathogenetical aspects. Ophthalmo-logica 1994; 208: 29-31.
53. Battaglia Parodi M, Ravalico G: Letter. Retina 1995; 15: 73-74.
54. Cousins SW, Flynn HW, Clarkson JG: Mac-roaneurysms associated with retinal branch vein occlusion. Am J Ophthalmol 1990; 109: 567-570.
55. Battaglia Parodi M, Da Pozzo S, Saviano S, Ravalico G: Branch retinal vein occlusion and macroaneurysms. Int Ophthalmol 1997; 21: 161-164.
56. Hayreh SS, Hayreh MS: Hemi-central retinal vein occlusion: pathogenesis, clinical features and natural history. Arch Ophthalmol 1980; 98: 1600-1609.
57. Hayreh SS: Letter. Ophthalmologica 1987; 194: 154-156.
58. Chopdar A: Hemispheric retinal vein occlusion or hemicentral retinal vein occlusion. Arch Ophthalmol 1986; 104: 1128.
59. Battaglia Parodi M, Moretti G, Ravalico G: Hemicentral and hemispheric retinal vein occlusions. Metab Pediatr Syst Ophthalmol 1992; 15: 64-67.
60. Sperduto RD, Hiller R, Chew E, et al.: Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion. The eye disease case-control study. Ophthalmology 1998; 105: 765-771.
61. Joffe L, Goldsberg RE, Magargal LE, Annes-ley WH: Macular branch vein occlusion. Ophthalmology 1980; 87: 91-98.
62. Notting JGA, Van Der Werf PJP: Macular changes caused by occlusion of a minute venous branch. Ophthalmologica 1976; 173: 200-206.
63. Battaglia Parodi M, Della Rupe P, Visintin F, Ravalico G: Foveal avascular zone in macular branch retinal vein occlusion. Int Oph-thalmol 1995; 19: 25-28.
64. Battaglia Parodi M, Saviano S, Ravalico G: Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 1999; 237: 1024-1027.
65. Virgili G, Caucci S, Lanzetta P, et al.: Retinal neovascularization in a case of macular branch retinal vein occlusion. Greafes Arch Clin Exp Ophthalmol 1997; 235: 603-605.
66. Houtsmuller AJ, Vermeulen JA, Klompe M, et al.: The influence of ticlopidine on the natural course of retinal vein occlusion. Agents Actions Suppl 1984; 15: 219-229.
67. Glacet-Bernard A, Coscas G, Chabanel A, et al.: A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol 1994; 118: 421-429.
68. Kiryu J, Ogura Y: Hyperbaric oxygen treatment for macular edema in retinal vein occlusion: relation to severity of retinal leakage. Ophthalmologica 1996; 210: 168-170.
69. Chen HC, Wiek J, Gupta A, et al.: Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol 1998; 82: 162-167.
70. Branch Vein Occlusion Study Group: Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984; 98: 271-282.
71. Shilling JS, Jones CA: Retinal branch vein occlusion: a study of argon laser photocoag-ulation in the treatment of macular edema. Br J Ophthalmol 1984; 68: 196-198.
72. Roseman RL, Olk RJ: Krypton red laser pho-tocoagulation for branch retinal vein occlusion. Ophthalmology 1987; 94: 1120-1125.
73. Finkelstein D: Ischemic macular edema: recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol 1992; 110: 1427-1434.
74. Battaglia Parodi M, Spasse S, Iacono P, et al.: Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology 2006; 113: 2237-2242.
75. Opremcak EM, Bruce RA: Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 1999; 19: 1-5.
76. Shah GH, Sharma S, Fineman MS, et al.: Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. Am J Oph-thalmol 2000; 129: 104-106.
77. Le Ruic JF, Bejjani RA, Rumen F, et al.: Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001; 239: 747-751.
78. Cahill MT, Kaiser PK, Sears JE, Fekrat S: The effect of arteriovemous sheathotomy on cys-toid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2003; 87: 1329-1332.
79. Mason J 3rd, Feist R, White M, et al.: Sheathotomy to decompress branch retinal vein occlusion. Ophthalmology 2004; 111: 540-545.
80. Yamamoto S, Saito W, Yagi F, et al.: Vitrec-tomy with and without arteriovenous adven-titial sheathotomy for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2004; 138: 907-914.
81. Kumagai K, Furukawa M, Ogino N, et al.: Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 2007; 27: 49-54.
82. Charbonnel J, Glacet-Bernard A, Korobelnik J, et al.: Management of branch retinal vein occlusion with vitrectomy and arteriove-nous adventitial sheathotomy: the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol 2004; 242: 223-228.
83. Tachi N, Hashimoto Y, Ogino N: Vitrectomy for macular oedema combined with retinal vein occlusion. Doc Ophthalmol 1999; 97: 465-469.
84. Amirikia A, Scott IU, Murray TG, et al.: Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion. Ophthalmology 2001; 108: 372-376.
85. Saika S, Tanaka T, Miyamoto T, Ohnishi Y: Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular oedema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Oph-thalmol 2001; 239: 729-732.
86. Stefansson E, Novack RL, Hatchell DL: Vit-rectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 1990; 31: 284-289.
87. Shimura M, Nakazawa T, Yasuda K, et al.: Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema. Acta Ophthalmol 2008; 86: 377-384.
88. Dagenring RF, Kamppeter B, Kreissig I, et al.: Morphological and functional changes after intravitreal triamcinolone for retinal vein occlusion. Acta Ophthalmol Scand 2003; 81: 548-550.
89. Chen SDM, Lochhead J, Patel CK, et al.: Intravitreal triamcinolone acetonide for isch-aemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 2004; 88: 154-155.
90. Jonas JB, Akkyyun I, Kamppeter B, et al.: Branch retinal vein occlusion treated by in-travitreal triamcinolone acetonide. Eye 2005; 19: 65-71.
91. Patel PJ, Zaheer I, Karia N: Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion. Eye 2008; 22: 60-64.
92. Cekic O, Chang S, Tseng JJ, et al.: Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 2005; 25: 851-855.
93. Hayashi K, Hayashi H: Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2005; 139: 972-982.
94. Kawaji T, Takano A, Inomata Y, et al.: Transide injection for macular oedema related to branch retinal vein occlusion. Br J Ophthal-mol 2008; 92: 81-83.
95. Kuppermann BD, Blumenkranz MS, Haller JA, et al.: Randomized controlled study of an intravitreous dexamathasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 2007; 125: 309-317.
96. Noma H, Funatsu H, Yamasaki M, et al.: Pathogenesisofmacularedemawithbranch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005; 140: 256-261.
97. Noma H, Minamoto A, Funatsu H, et al.: Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2006; 244: 309-315.
98. Pai SA, Shetty R, Vijiayan PB, et al.: Clinic, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007; 143: 601-606.
99. Rabena MD, Pieramici DJ, Castellarin AA, et al.: Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007; 27: 419-425.
100. Kreutzer TC, Alge CS, Wolf AH, et al.: In-travitreal bevacizumab for the treatment of macula oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2008; 92: 351-355.
101. Wu L, Arevalo JF, Roca JA, et al.: Comparison of two doses of intravitreal bevacizu-mab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from Pan-American Collaborative Retina Study Group at 6 months of follow-up. Retina 2008; 28: 212-219.
102. Funk M, Kriechbaum KF, Prager F, et al.: Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci 2009; 50: 1025-1032.
103. Jaissle GB, Leitritz M, Gelisken F, et al.: One-year results after intravitreal bevaci-zumab therapy for macular edema secondary to branch retinal vein occlusion. Grae-fes Arch Clin Exp Ophthalmol 2009; 247: 27-33.
104. Prager F, Michels S, Kriechbaum K, et al.: Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: twelve-month results of a prospective clinical trial. Br J Ophthalmol 2009; 93: 452-456. DOI: 10.1136/bjo.2008. 141085.
105. Chung EJ, Hong YT, Lee SC, et al.: Prognostic factors for visual outcome after intravit-real bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1241-1247.
106. Campochiaro PA, Hafiz G, Shah SM, et al.: Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther 2008; 16: 791-799.
107. Riese J, Loukopoulos V, Meier C, et al.: Combined intravitreal triamcinlone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1671-1676.
108. Cakir M, Dogan M, Bayraktar Z, et al.: Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with and without grid laser photocoagulation. Retina 2008; 28: 465-472.
109. Parodi MB, Iacono P, Ravalico G: Intravit-real triamcinolone acetonide combined with subthreshold grid laser treatment for macular oedema in branch retinal vein occlusion: a pilot study. Br J Ophthalmol 2008; 92: 1046-1050.
110. Jin M, Ke Y, Zheng Z, Xiajing T: Twenty-five-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic macular edema associated with branch retinal vein occlusion. Retina 2008; 28: 947-956.
111. Uemura A, Yamamoto S, Sato E, et al.: Vit-rectomy alone versus vitrectomy with simultaneous injection of triamcinolone for macular edema associated with branch retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2009; 40: 6-12.
112. Garcia-Arumi J, Martinez-Castillo V, Boixadera A, et al.: Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina 2004; 24: 530-540.